CoChat
Sign Up
Cited by 83

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Outcomes of Unrelated Umbilical Cord Blood Transplantation for X-Linked Adrenoleukodystrophy

Beam, Donald, Poe, Michele D., Provenzale, James M., Szabolcs, Paul, Martin, Paul L., Prasad, Vinod, Parikh, Suhag, Driscoll, Tim, Mukundan, Srini, Kurtzberg, Joanne, Escolar, Maria L.·2007·Biology of Blood and Marrow Transplantation
DOI 10.1016/j.bbmt.2007.01.082
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbmt.2007.01.082

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 (a) Overall survival after transplantation. Kaplan-Meier estimates of the probability of overall survival. Cumulative incidence of overall survival at 6.25 months was 66.7% (95% confidence interval 39.9%-93.3%). (b) Cumulative incidence of acute GVHD grades II-IV (n = 10, 2 events). Cumulative incidence at day 100: 40.0% (95% confidence interval 7.5%-72.5%). (c) Cumulative incidence of chronic GVHD (n = 10, 2 events). Cumulative incidence at day 365: 10.0% (95% confidence interval 0.0%-29.6%) CINC at day 730: 22.9% (95% confidence interval 0.0%-53.2%).
Figure 1 (a) Overall survival after transplantation. Kaplan-Meier estimates of the probability of overall survival. Cumulative incidence of overall survival at 6.25 months was 66.7% (95% confidence interval 39.9%-93.3%). (b) Cumulative incidence of acute GVHD grades II-IV (n = 10, 2 events). Cumulative incidence at day 100: 40.0% (95% confidence interval 7.5%-72.5%). (c) Cumulative incidence of chronic GVHD (n = 10, 2 events). Cumulative incidence at day 365: 10.0% (95% confidence interval 0.0%-29.6%) CINC at day 730: 22.9% (95% confidence interval 0.0%-53.2%).CC-BY-NC-ND · From the PDF
Figure 2 (a-f) Developmental function by domain. Each patient's development is represented by a unique color line. The green diagonal line represents typical population development. The gray area represents the approximate normal 95% range in the general population.
Figure 2 (a-f) Developmental function by domain. Each patient's development is represented by a unique color line. The green diagonal line represents typical population development. The gray area represents the approximate normal 95% range in the general population.CC-BY-NC-ND · From the PDF
Figure 3 (a) Cognitive development and pretransplant MRI Loes scores. The green line represents typical development. Each blue line represents the longitudinal cognitive course of a surviving patient with baseline Loes Scores < 10. The red lines represent the longitudinal cognitive course of surviving patients with Loes Scores > 10. The black and purple represent deceased patients. (b) Gross motor development and pretransplant MRI Loes scores. The green line represents typical development. Each blue line represents the longitudinal motor course of a surviving patient with baseline Loes scores < 10. The red lines represent the longitudinal motor course of surviving patients with Loes scores > 10. The black and purple represent deceased patients. Note that motor scores are in general lower than cognitive scores in (a).
Figure 3 (a) Cognitive development and pretransplant MRI Loes scores. The green line represents typical development. Each blue line represents the longitudinal cognitive course of a surviving patient with baseline Loes Scores < 10. The red lines represent the longitudinal cognitive course of surviving patients with Loes Scores > 10. The black and purple represent deceased patients. (b) Gross motor development and pretransplant MRI Loes scores. The green line represents typical development. Each blue line represents the longitudinal motor course of a surviving patient with baseline Loes scores < 10. The red lines represent the longitudinal motor course of surviving patients with Loes scores > 10. The black and purple represent deceased patients. Note that motor scores are in general lower than cognitive scores in (a).CC-BY-NC-ND · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 19

  1. Moser, 1980, Adrenoleukodystrophy: studies of the phenotype, genetics and biochemistry, Johns Hopkins Med J, 147, 217
  2. Schaumburg, 1975, Adrenoleukodystrophy, Arch Neurol, 32, 577, 10.1001/archneur.1975.00490510033001 · DOI · Paper page
  3. Moser, 1994, The gene responsible for adrenoleukodystrophy encodes a peroxisomal membrane protein, Hum Mol Genet, 3, 265, 10.1093/hmg/3.2.265 · DOI · Paper page
  4. Krivit, 1999, Curr Opin Neurol, 12, 167, 10.1097/00019052-199904000-00007 · DOI
  5. Suzuki, 2000, Bone marrow transplantation for the treatment of X-linked adrenoleukodystrophy, J Inherit Metab Dis, 23, 453, 10.1023/A:1005656029200 · DOI
  6. Sauer, 2004, Hematopoietic stem cell transplantation for mucopolysaccharidoses and leukodystrophies, Klin Padiatr, 216, 163, 10.1055/s-2004-822629 · DOI
  7. Peters, 2004, Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999, Blood, 104, 881, 10.1182/blood-2003-10-3402 · DOI · Paper page
  8. Gluckman, 1989, Hematopoietic reconstitution in a patient with Fanconi’s anemia by means of umbilical-cord blood from an HLA-identical sibling, N Engl J Med, 321, 1174, 10.1056/NEJM198910263211707 · DOI
  9. Kurtzberg, 1996, Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients, N Engl J Med, 335, 157, 10.1056/NEJM199607183350303 · DOI
  10. Martin, 2006, Results of the Cord Blood Transplantation Study (COBLT): outcomes of unrelated umbilcal cord transplantation in pediatric patients with lysosomal and peroxisomal storage disorders, Biol Blood MarrowTransplant, 12, 184, 10.1016/j.bbmt.2005.09.016 · DOI
  11. Staba, 2004, Cord-blood transplants from unrelated donors with Hurlers syndrome, N Engl J Med, 350, 1960, 10.1056/NEJMoa032613 · DOI
  12. Escolar, 2005, Transplantation of umbilical-cord blood in babies with infantile Krabbe’s disease, N Engl J Med, 352, 2069, 10.1056/NEJMoa042604 · DOI
  13. Jacobson, 2001, Oral busulfan pharmacokinetics and engraftment in children with Hurler Syndrome and other inherited metabolic storage diseases undergoing hematopoetic stem cell transplant, Bone Marrow Transplant, 27, 855, 10.1038/sj.bmt.1703010 · DOI
  14. Rubinstein, 1995, Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution, Proc Natl Acad Sci U S A, 92, 10119, 10.1073/pnas.92.22.10119 · DOI
  15. Przepiorka, 1995, 1994 Consensus conference on acute GVHD grading, Bone Marrow Transplant, 15, 825
  16. Loes, 1994, Adrenoleukodystrophy: a scoring method for brain MR observations, Am J Neuroradiol, 15, 1761
  17. Society, 1994, Guideline nine: guidelines on evoked potentials, J Clin Neurophysiol, 11, 40, 10.1097/00004691-199401000-00010 · DOI
  18. Moser, 2005, Follow up of 89 asymptomatic patients with adrenoleukodystrophy treated with Lorenzo’s oil, Arch Neurol, 62, 1073, 10.1001/archneur.62.7.1073 · DOI · Paper page
  19. Smalley, 1966, Two cases of busulfan toxicity, Ann Intern Med, 64, 154, 10.7326/0003-4819-64-1-154 · DOI

Cited by

Metadata

Authors
Beam, D., Poe, M. D., Provenzale, J. M., Szabolcs, P., Martin, P. L., Prasad, V., Parikh, S., Driscoll, T., Mukundan, S., Kurtzberg, J., & Escolar, M. L.
Venue
Biology of Blood and Marrow Transplantation
Publisher
Elsevier BV
Published
2007-06
Volume
13
Issue
6
Pages
665-674
ISSN
1083-8791
DOI
10.1016/j.bbmt.2007.01.082
Cited by
83
References
3
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review